Cargando…

Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines

Detalles Bibliográficos
Autores principales:	van Griensven, Johan, Ritmeijer, Koert, Lynen, Lutgarde, Diro, Ermias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102411/ https://www.ncbi.nlm.nih.gov/pubmed/25032826 http://dx.doi.org/10.1371/journal.pntd.0002916

Ejemplares similares

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
por: Boodman, Carl, et al.
Publicado: (2023)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

A Screen-and-Treat Strategy Targeting Visceral Leishmaniasis in HIV-Infected Individuals in Endemic East African Countries: The Way Forward?
por: van Griensven, Johan, et al.
Publicado: (2014)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
por: Abongomera, Charles, et al.
Publicado: (2017)

High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2014)

Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia
por: Endris, Mengistu, et al.
Publicado: (2014)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study
por: Diro, Ermias, et al.
Publicado: (2015)

The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study
por: Abongomera, Charles, et al.
Publicado: (2017)

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study
por: Abongomera, Charles, et al.
Publicado: (2018)

Impact of the Use of a Rapid Diagnostic Test for Visceral Leishmaniasis on Clinical Practice in Ethiopia: A Retrospective Study
por: Diro, Ermias, et al.
Publicado: (2015)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
por: van Griensven, Johan, et al.
Publicado: (2018)

Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
por: Aderie, Endashaw M., et al.
Publicado: (2017)

Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia
por: Vogt, Florian, et al.
Publicado: (2018)

Visceral Leishmaniasis Relapse in HIV Patients—A Role for Myeloid-Derived Suppressor Cells?
por: Van den Bergh, Rafael, et al.
Publicado: (2014)

Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia
por: Mohammed, Rezika, et al.
Publicado: (2020)

Case Report: Atypical Presentation of Visceral Leishmaniasis: Two Cases from Northwest Ethiopia
por: Mohammed, Rezika, et al.
Publicado: (2021)

Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
por: Diro, Ermias, et al.
Publicado: (2018)

Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration
por: Mohammed, Rezika, et al.
Publicado: (2021)

Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2019)

Shigella Bacteremia in a Patient with Visceral Leishmaniasis
por: Endris, Mengistu, et al.
Publicado: (2013)

Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV
por: Adriaensen, Wim, et al.
Publicado: (2020)

Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia
por: Hailu, Workagegnehu, et al.
Publicado: (2021)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
por: van Griensven, Johan, et al.
Publicado: (2016)

Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review
por: van Griensven, Johan, et al.
Publicado: (2016)

Visceral Leishmaniasis and Arsenic: An Ancient Poison Contributing to Antimonial Treatment Failure in the Indian Subcontinent?
por: Perry, Meghan R., et al.
Publicado: (2011)

A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan
por: Kämink, Suzette S., et al.
Publicado: (2017)

Outcomes of visceral leishmaniasis in pregnancy: A retrospective cohort study from South Sudan
por: Pekelharing, Judith E., et al.
Publicado: (2020)

Accounting for False Positive HIV Tests: Is Visceral Leishmaniasis Responsible?
por: Shanks, Leslie, et al.
Publicado: (2015)

A Poor-Quality Generic Drug for the Treatment of Visceral Leishmaniasis: A Case Report and Appeal
por: Dorlo, Thomas P. C., et al.
Publicado: (2012)

One More Death from Visceral Leishmaniasis Has Gone by Unnoticed. What Can Be Done?
por: Matlashewski, Greg, et al.
Publicado: (2013)

Cutaneous Leishmaniasis Due to Leishmania aethiopica
por: van Henten, Saskia, et al.
Publicado: (2019)

Visceral Leishmaniasis Relapse in Southern Sudan (1999–2007): A Retrospective Study of Risk Factors and Trends
por: Gorski, Stanislaw, et al.
Publicado: (2010)

Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action
por: van Griensven, Johan, et al.
Publicado: (2014)

Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
por: Tamiru, Aschalew, et al.
Publicado: (2016)

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans
por: Dahal, Prabin, et al.
Publicado: (2021)

Where Do We Go From Here? Defining an Agenda for Home-Based Records Research and Action Considering the 2018 WHO Guidelines
por: Brown, David W., et al.
Publicado: (2019)

A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2019)

Evaluation of the 2007 WHO Guideline to Improve the Diagnosis of Tuberculosis in Ambulatory HIV-Positive Adults
por: Koole, Olivier, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1a8ptrj85liea92nvfrvihnvis